Medtronic (MDT) Capital Expenditures (2014 - 2026)

Medtronic's Capital Expenditures history runs 13 years deep, the most recent figure standing at $444.0 million for Q1 2026.

• In Q1 2026, Capital Expenditures fell 6.72% year-over-year to $444.0 million; the TTM figure through Jan 2026 stood at $1.9 billion (up 2.68% YoY), while the FY2025 annual figure was $1.9 billion, up 17.14% from the prior year.
• Capital Expenditures came in at $444.0 million for Q1 2026 at Medtronic, down from $468.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $520.0 million in Q3 2024 to a low of $323.0 million in Q4 2022.
• A 5-year average of $414.1 million and a median of $426.0 million in 2022 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures declined 16.9% in 2023 and soared 46.89% in 2024, its largest moves.
• Medtronic's Capital Expenditures stood at $323.0 million in 2022, then surged by 42.72% to $461.0 million in 2023, then fell by 12.36% to $404.0 million in 2024, then advanced by 15.84% to $468.0 million in 2025, then slipped by 5.13% to $444.0 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $444.0 million, $468.0 million, and $504.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison